Manufacturing and Production

Showing 15 posts of 5860 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer dominated the headlines this week as the US firm closed its $9.8 billion merger with GSK and announced that …
merckentranceweb

MSD to bring over 400 new jobs to North Carolina with two site expansions

July 31, 2019 Manufacturing and Production, Research and Development MSD, US, pharma

MSD has announced a $650 million expansion of its existing facilities in North Carolina – a move which is bring …

Bayer’s Vitravki poised to become first tumour-agnostic therapy in EU following CHMP recommendation

July 30, 2019 Manufacturing and Production, Sales and Marketing Bayer, CHMP, Cancer, EU, Vitrakvi, pharma

Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) could be set to become the European Union’s first drug approved in a tumour-agnostic …
bacteria-3662695_960_720

Extremely antibiotic resistant superbugs spreading in hospitals across Europe

July 30, 2019 Manufacturing and Production AMR, Antibiotics, drug resistance, drug resistant bacteria, pharma

Antibiotic resistant superbugs are spreading in hospitals in Europe, according to a study published in Nature Microbiology. The research shows …
merck-keytruda

MSD’s Keytruda combo hits primary endpoint at Phase 3 in triple-negative breast cancer

July 30, 2019 Manufacturing and Production, Research and Development Cancer, MSD, breast cancer, keytruda, pharma

MSD’s blockbuster anti-PD-L1 immunotherapy Keytruda (pembrolizumab) has impressed in newly released Phase 3 data; the company announced that, when combined …
teva_copy

Teva, Endo and Teikoku pay $70 million settlement to California

July 30, 2019 Manufacturing and Production

Three pharmaceutical companies have agreed to pay $70 million to the state of California for keeping drug prices artificially high. …

Pfizer to combine off-patent drug unit Upjohn with Mylan

July 30, 2019 Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers

Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …
survey-2316468_640

The patient is always right: Extracting the full value of PROMs

July 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biohaven, FDA, Lyrica, NICE, Pfizer, UK, US, pharma, top ten

At the end of a week that could certainly be called “eventful” here in the UK – one that saw …
reshma-bio-image

Vertex promote chief medical officer to CEO as Jeffrey Leiden steps down

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Reshma Kewalramani has been made the new Vertex CEO. Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO …
christi_shaw

Christi Shaw taken on by Gilead as Kite Pharma’s new CEO

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lilly veteran Christi Shaw has joined Kite Pharma as the company’s new CEO. Shaw comes to Gilead’s cancer immunotherapy firm, …
jonathan_symonds

GSK hire Jonathan Symonds as new Chairman

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …
dr_alvin_shih

Disarm Therapeutics hires Dr Alvin Shih as new President and CEO

July 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Massachusetts-based biotech Disarm Therapeutics has hired Dr Alvin Shih as their new President and CEO. The Cambridge, Mass.-based firm has …
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous formulation of Entyvio smashes primary endpoint in Crohn’s disease

July 23, 2019 Manufacturing and Production, Research and Development Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has unveiled new Phase 3 data for a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab), showing that the …
The Gateway to Local Adoption Series

Latest content